Percutaneous closure of a paravalvular leak may be utilized to manage severe anemia in patients with artificial mitral valves.
May support percutaneous closure as an option for severe anemia post-mitral replacement; leaves open need for prospective validation.
Hemolytic anemia after implantation of an artificial mitral valve is a rare but recognized complication of surgery.[1],[2] The presence of paravalvular leak after surgery and the necessity of using oral anticoagulants causes that anemia emerges as a severe and potentially fatal issue.[3]
No takes yet. Share an insight, caveat, or question.
Pelczarska et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: